Opportunity Information: Apply for CDC RFA GH13 1303
Apply for CDC RFA GH13 1303
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Building Systems and Capacity within the Cambodian Ministry of Health to Prevent New HIV Infections and AIDS Related Deaths in Cambodia through PEPFAR Support to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) under the Presidents Em" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Feb 21, 2013 and posted on Dec 19, 2012.
- Applicants must submit their applications by Mar 13, 2013. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $7,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligibility is limited to the National Center for HIV/AIDS, Dermatology, and STDS (NCHADS) only
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity (CDC RFA GH13-1303) is a CDC discretionary cooperative agreement under CFDA 93.067 (Global AIDS) designed to strengthen Cambodia's national HIV program through direct support to the Ministry of Health's National Center for HIV/AIDS, Dermatology, and STDs (NCHADS). The overall aim is to provide both financial and technical assistance for an ongoing collaboration that helps NCHADS improve how it plans, manages, measures, and sustains national HIV efforts, aligning those efforts with the "three zeros" vision: zero new HIV infections, zero AIDS-related deaths, and zero stigma and discrimination, with a stated target of achieving these outcomes by 2020.
A central theme of the announcement is building systems and capacity inside government, not running a parallel program outside it. The work is framed around improving national strategies and day-to-day performance, strengthening monitoring and evaluation, increasing cost efficiency, and making services more sustainable over time. Because the funding instrument is a cooperative agreement, the CDC is expected to remain substantially involved in the work, typically through close technical collaboration, joint planning, and ongoing performance monitoring rather than simply issuing funds and stepping back.
The programmatic focus areas highlight specific HIV outcomes across the prevention-to-treatment continuum. One priority is the virtual elimination of new pediatric HIV infections, which generally implies strengthening prevention of mother-to-child transmission approaches, earlier identification of pregnant women living with HIV, timely initiation of effective antiretroviral therapy, and strong follow-up for exposed infants. Another priority is improving the quality of the continuum of care for people living with HIV, with special attention to individuals who also have tuberculosis, reflecting the high clinical risk and programmatic complexity of HIV/TB co-infection and the need for integrated screening, diagnosis, and treatment services. The announcement also emphasizes early treatment as prevention, pointing to program improvements that promote timely diagnosis and rapid initiation of antiretroviral therapy to reduce onward transmission and improve health outcomes.
The funding profile indicates an anticipated single award, with an estimated total funding amount of $7,500,000 and an annual award ceiling of $1,500,000 (award floor listed as $0). There is no cost sharing or matching requirement. The opportunity was posted on December 19, 2012, with a closing date of March 13, 2013, and an archive date of April 12, 2013, indicating it is no longer open for applications. Eligibility is explicitly restricted to NCHADS only, meaning the Cambodian government entity itself is the sole eligible applicant rather than universities, NGOs, or other external organizations.
In practical terms, the opportunity is about strengthening Cambodia's national HIV response through improved governance and execution: better strategies, better performance management, stronger monitoring of results, more efficient use of resources, and long-term sustainability of Ministry of Health approaches, while focusing service delivery and program quality on pediatric HIV elimination, stronger HIV care outcomes (especially for HIV/TB), and earlier treatment to reduce new infections and prevent avoidable AIDS-related deaths. For access issues related to the full announcement, the listed point of contact is the CDC Procurement and Grants Office Technical Information Management (telephone 770-488-2700; email pgotim@cdc.gov).
Frequently Asked Questions (FAQs) - CDC RFA GH13-1303 (Cambodia Global AIDS Cooperative Agreement)
1) What is CDC RFA GH13-1303?
CDC RFA GH13-1303 is a CDC discretionary cooperative agreement under CFDA 93.067 (Global AIDS). It is designed to strengthen Cambodia's national HIV program by providing direct support to the Ministry of Health's National Center for HIV/AIDS, Dermatology, and STDs (NCHADS).
2) What is the main purpose of this funding opportunity?
The overall aim is to provide both financial and technical assistance for an ongoing collaboration that helps NCHADS improve how it plans, manages, measures, and sustains national HIV efforts in Cambodia.
3) What does the "three zeros" vision mean in this announcement?
The announcement aligns national HIV efforts with the "three zeros" vision: zero new HIV infections, zero AIDS-related deaths, and zero stigma and discrimination. It also states a target of achieving these outcomes by 2020.
4) Who is the intended recipient of the award?
The award is intended to directly support Cambodia's Ministry of Health entity NCHADS (National Center for HIV/AIDS, Dermatology, and STDs).
5) Who is eligible to apply?
Eligibility is explicitly restricted to NCHADS only. Universities, NGOs, and other external organizations are not eligible applicants under this announcement.
6) Is this opportunity still open for applications?
No. The opportunity was posted on December 19, 2012, with a closing date of March 13, 2013, and an archive date of April 12, 2013. These dates indicate it is no longer open for applications.
7) What type of award is this: grant or cooperative agreement?
This is a cooperative agreement. The announcement describes it as a CDC discretionary cooperative agreement rather than a standard grant.
8) What does it mean that this is a cooperative agreement?
Because it is a cooperative agreement, the CDC is expected to remain substantially involved in the work. The involvement is described as close technical collaboration, joint planning, and ongoing performance monitoring, rather than simply issuing funds without continued engagement.
9) What is CFDA 93.067?
CFDA 93.067 is identified in the announcement as "Global AIDS." This opportunity falls under that CFDA listing.
10) How many awards does the CDC anticipate making?
The funding profile indicates an anticipated single award.
11) What is the total estimated funding amount?
The estimated total funding amount is $7,500,000.
12) What is the annual award ceiling?
The annual award ceiling is listed as $1,500,000.
13) What is the award floor and what does it imply?
The award floor is listed as $0. The announcement does not provide additional explanation beyond that listing.
14) Is cost sharing or matching required?
No. The announcement states there is no cost sharing or matching requirement.
15) What is the central implementation theme of the announcement?
A central theme is building systems and capacity inside the government, not running a parallel program outside it. The work is framed around strengthening national strategies and day-to-day performance within NCHADS and the Ministry of Health context.
16) What kinds of improvements is the collaboration expected to support?
The announcement emphasizes improvements in national planning, management, measurement, and sustainability of HIV efforts. It highlights strengthening monitoring and evaluation, increasing cost efficiency, and making services more sustainable over time.
17) What parts of the HIV response does the announcement focus on?
The programmatic focus areas include outcomes across the prevention-to-treatment continuum. Priorities include eliminating new pediatric HIV infections, improving the continuum of HIV care, strengthening attention to HIV/TB co-infection, and promoting early treatment as prevention.
18) What does "virtual elimination of new pediatric HIV infections" refer to in this context?
In this announcement, it is described in terms of strengthening prevention of mother-to-child transmission approaches, earlier identification of pregnant women living with HIV, timely initiation of effective antiretroviral therapy, and strong follow-up for HIV-exposed infants.
19) How does the opportunity address the HIV care continuum?
It prioritizes improving the quality of the continuum of care for people living with HIV, emphasizing better performance and program quality from diagnosis through treatment and follow-up.
20) Why is HIV/TB co-infection specifically highlighted?
The announcement calls special attention to individuals who also have tuberculosis because HIV/TB co-infection is described as high risk and programmatically complex, requiring integrated screening, diagnosis, and treatment services.
21) What does "early treatment as prevention" mean in this announcement?
The announcement emphasizes program improvements that promote timely diagnosis and rapid initiation of antiretroviral therapy. It links earlier treatment to reducing onward transmission and improving health outcomes.
22) What does the announcement say about sustainability?
It emphasizes making services more sustainable over time and improving the ability of NCHADS to sustain national HIV efforts through stronger systems, performance management, monitoring, and efficient use of resources.
23) What does the announcement imply about governance and performance management?
It frames the work around better national strategies, better day-to-day performance, stronger monitoring of results, and more efficient resource use, all within the national program structure rather than outside it.
24) Who should be contacted for access issues related to the full announcement?
For access issues, the listed point of contact is the CDC Procurement and Grants Office Technical Information Management. Telephone: 770-488-2700. Email: pgotim@cdc.gov.
25) What are the key dates listed for this opportunity?
The opportunity was posted on December 19, 2012. The closing date was March 13, 2013. The archive date was April 12, 2013.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Support of Advanced Coal Research at U.S. Colleges and Universities
Previous opportunity: Early Warning Program to Detect and Identify Emerging Contaminants and Their Effects to Fish and Wildlife
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH13 1303
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH13 1303) also looked into and applied for these:
| Funding Opportunity |
|---|
| Strengthening Global Animal Human Interface Activities for Avian Influenza and other Zoonotic Diseases Apply for RFA CK 13 002 Funding Number: RFA CK 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $500,000 |
| Epidemiology, Prevention and Treatment of Influenza and other Respiratory Infections in Panama and Central America Region Apply for RFA IP 13 002 Funding Number: RFA IP 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,000,000 |
| Grants to States to Support Oral Health Workforce Activities Apply for HRSA 13 142 Funding Number: HRSA 13 142 Agency: Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Partnering with the Ministry of Health of Vietnam to Build a Sustainable System for HIV/AIDS Prevention, Care, and Treatment in the Socialist Republic of Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH13 1304 Funding Number: CDC RFA GH13 1304 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $12,000,000 |
| NIDCD Clinical Research Center Grant (P50) Apply for PAR 13 062 Funding Number: PAR 13 062 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Nationwide Program for National and State Background Checks for Direct Patient Access Employees of Long Term Care Facilities and Providers Apply for CMS 1A1 13 001 Funding Number: CMS 1A1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $3,000,000 |
| Interdisciplinary Complementary and Integrative Health Clinical Research Training Award (T90/R90) Apply for PAR 13 065 Funding Number: PAR 13 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Strengthening the Monitoring and Evaluation of Programs for the Elimination and Control of Neglected Tropical Diseases in Africa Apply for RFA GH 13 002 Funding Number: RFA GH 13 002 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $9,000,000 |
| Exemplar Health Information Exchange Governance Entities Program Apply for HIEGE HG 12 001 Funding Number: HIEGE HG 12 001 Agency: Office of the National Coordinator Category: Health Funding Amount: $400,000 |
| Research in latent tuberculosis infection (LTBI) in the setting of HIV Co Infection (R01) Apply for PAR 13 061 Funding Number: PAR 13 061 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Integrating Newborn Screening Long term Follow up into Primary Care Practices Apply for HRSA 13 213 Funding Number: HRSA 13 213 Agency: Health Resources and Services Administration Category: Health Funding Amount: $110,000 |
| Limited Competition Initiative to Maximize Research Education in Genomics (R25) Diversity Action Plan Apply for PAR 13 063 Funding Number: PAR 13 063 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Building healthcare practitioner capacity around HPV Vaccine Communication Apply for RFA IP 13 001 Funding Number: RFA IP 13 001 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $300,000 |
| Revisions for Macromolecular Interactions in Cells (R01) Apply for RFA GM 14 003 Funding Number: RFA GM 14 003 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Telehealth Resource Center Grant Program Apply for HRSA 13 167 Funding Number: HRSA 13 167 Agency: Health Resources and Services Administration Category: Health Funding Amount: $325,000 |
| Implementation Support for State Demonstrations to Integrate Care for Medicare Medicaid Enrollees Apply for CMS 1I1 13 001 Funding Number: CMS 1I1 13 001 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $15,000,000 |
| Sober Truth on Preventing Underage Drinking Act Grants Apply for SP 13 001 Funding Number: SP 13 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $50,000 |
| The CDCs National Undergraduate Student Program A Public Health Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 1101 Funding Number: CDC RFA MN11 1101 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,850,000 |
| FY 2013 Cooperative Agreements for the National Suicide Prevention Lifeline Crisis Center Follow Up Apply for SM 13 002 Funding Number: SM 13 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $60,000 |
| Planning Grants for Expansion of the Comprehensive Community Mental Health Services for Children and Their Families Apply for SM 13 001 Funding Number: SM 13 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $800,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH13 1303", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.